Skip to main content
Veterinary Medicines

Bovilis IBR marker live, ninatilgad, suspensiooni lüofilisaat ja lahusti veistele

Authorised
  • Infectious Bovine rhinotracheitis virus, strain GK/D gE gene-deleted, Live

Product identification

Medicine name:
Bovilis IBR marker live, ninatilgad, suspensiooni lüofilisaat ja lahusti veistele
Active substance:
  • Infectious Bovine rhinotracheitis virus, strain GK/D gE gene-deleted, Live
Target species:
  • Cattle
Route of administration:
  • Nasal use
  • Intramuscular use

Product details

Active substance and strength:
  • Infectious Bovine rhinotracheitis virus, strain GK/D gE gene-deleted, Live
    19952600.00
    tissue culture infective dose 50
    /
    1.00
    dose
Pharmaceutical form:
  • Nasal drops, lyophilisate and solvent for suspension
Withdrawal period by route of administration:
  • Nasal use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AD01
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1208
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 3/10/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."